Ubs Ag Etracs Gold Shares Covered Call Etn logo

Ubs Ag Etracs Gold Shares Covered Call Etn(GLDI)

$153.19-0.16%

Market is closed - opens 7 PM, 09 Sep 2024

Insights

  • Ubs Ag Etracs Gold Shares Covered Call Etn is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Ubs Ag Etracs Gold Shares Covered Call Etn stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Ubs Ag Etracs Gold Shares Covered Call Etn stock is in a uptrend ↗️
  • Based on analysis of the Pivot Points, the current market trend for Ubs Ag Etracs Gold Shares Covered Call Etn stock suggests that it is a good time to buy

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
57.64
Neutral
Stochastic
48.47, 40.68
Neutral
Ultimate Oscillator
50.95
Neutral
Stochastic Relative Strength Index
27.99, 30.66
Neutral
Moving Average Convergence Divergence
0.63, 0.7
Sell

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
153.08
Buy
20
152.93
Buy
50
151.16
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
153.13
Buy
20
152.71
Buy
50
151.61
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
153.05
Neutral
20
153.17
Neutral
50
151.69
Neutral

Double Exponential Moving Average

Period (Days)

Value

Action

10
153.42
Sell
20
153.6
Buy
50
152.8
Buy

Triple Exponential Moving Average

Period (Days)

Value

Action

10
153.27
Sell
20
153.6
Sell
50
153.67
Buy

Pivot

Pivot

Value

Resistance L3
153.45
Resistance L2
153.36
Resistance L1
153.17
Pivot Point
153.08
Support L1
152.9
Support L2
152.81
Support L3
152.62

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.